SCHEMBL196635

SCHEMBL196635

CN(CC(=O)O)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.49
MEN1 O00255 3/20 0.49
NLRP3 Q96P20 1/20 0.49
CA12 O43570 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47
ALDH1A1 P00352 3/20 0.47
GLA P06280 1/20 0.47
TSHR P16473 1/20 0.47
RXFP1 Q9HBX9 1/20 0.46
NPSR1 Q6W5P4 2/20 0.44
OPRM1 P35372 1/20 0.44
OPRL1 P41146 1/20 0.44
HTT P42858 2/20 0.43
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NPC1 O15118 1/20 0.42
POLB P06746 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11973878 0.98 KMT2A (0.47) KMT2AMEN1NLRP3CA12CA2
Hydrochloric Acid SCHEMBL2238154 0.98 KMT2A (0.47) KMT2AMEN1NLRP3CA12CA2
Ethane SCHEMBL7405342 0.98 KMT2A (0.47) KMT2AMEN1NLRP3CA12CA2
SCHEMBL11973371 0.98 KMT2A (0.47) KMT2AMEN1NLRP3CA12CA2
SCHEMBL14067916 0.88 ALDH1A1 (0.53) ALDH1A1TSHRHTTSMN1; SMN2RAB9A
SCHEMBL1547824 0.86 KMT2A (0.49) KMT2AMEN1NLRP3CA12CA2
SCHEMBL9456006 0.83 FFAR1 (0.46) CA12CA2CA9ALDH1A1KDM4E
Phenylglycine SCHEMBL7929007 0.83 RXFP1 (0.40) KMT2AMEN1NLRP3RXFP1
SCHEMBL29367590 0.83 OPRM1 (0.47) KMT2AMEN1NLRP3CA12CA2
SCHEMBL3348892 0.83 KEAP1 (0.54) KMT2ACA12CA2CA9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1043 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250186634-A1 METHODS OF TREATING SMALL CELL LUNG CANCER Evergreen Discovery, LLC (US) 2025-06-12 US claimed
CN-119280498-B Hydrophilic coating on surface of interventional guide wire as well as preparation process and application thereof 深圳麦普奇医疗科技有限公司 2025-03-25 CN claimed
CN-119280498-A Hydrophilic coating on surface of interventional guide wire as well as preparation process and application thereof 深圳麦普奇医疗科技有限公司 2025-01-10 CN claimed
CN-119024642-A Photocurable resin composition, application thereof and photosensitive dry film resist laminate 杭州福斯特电子材料有限公司 2024-11-26 CN claimed
CN-118239879-A Method for preparing 3-substituted oxindole, dihydroisoindigo and tetra-substituted ethane based on primary amine and application of primary amine 泰山学院 2024-06-25 CN claimed
CN-117658914-A Naphthalimide photoinitiator, photopolymerizable liquid composition, method and application 大连理工大学 2024-03-08 CN claimed
CN-114196226-B Coumarin dye, composite initiator for ultrasonic curing, preparation method and application thereof 大连理工大学 2024-02-13 CN claimed
CN-115872881-A Synthesis method of menthol amine compound and application of menthol amine compound in cigarettes 云南中烟工业有限责任公司 2023-03-31 CN claimed
CN-114196226-A Coumarin dye, composite initiator for ultrasonic curing, preparation method and application thereof 大连理工大学 2022-03-18 CN claimed
EP-3628680-B1 MODULATION OF COMPLEMENT ACTIVITY RA PHARMACEUTICALS INC (US) 2021-09-08 EP claimed
EP-1006122-A1 PHENETHYLAMINE DERIVATIVES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2000-06-07 EP claimed
US-5504071-A HYPOTENSIVE AGENTS POLIFARMA S.P.A. (IT) 1996-04-02 US claimed
EP-0421366-B1 Radiolabeled anticoagulant peptides MERRELL DOW PHARMA (US) 1995-07-19 EP claimed
US-5401783-A Adhesion-promoting agents incorporating polyvalent cations AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION (US) 1995-03-28 US claimed
EP-0276014-B1 Anticoagulant peptides MERRELL DOW PHARMA (US) 1994-08-31 EP claimed
EP-0578521-A1 New peptide derivatives with bradykinin-antagonistic activity, process to prepare them and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1994-01-12 EP claimed
US-5270351-A Adhesion-promoting agents incorporating polyvalent cations AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION (US) 1993-12-14 US claimed
EP-0291982-B1 CYCLIC ANTICOAGULANT PEPTIDES MERRELL DOW PHARMACEUTICALS INC. (US) 1993-07-14 EP claimed
US-5153236-A Comprising an N-aryl-alpha-amino acid and a photosensitizer such as a thixoanthone, isoalloxazine or coumarine; high sensitivity to UV and visible light; storage stability; photoresists; relief images HITACHI CHEMICAL CO., LTD. (JP) 1992-10-06 US claimed
EP-0000932-B1 PRODUCTION OF N-ACYL-THIENAMYCINS MERCK & CO. INC. (US) 1981-10-21 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250186634-A1 METHODS OF TREATING SMALL CELL LUNG CANCER SSTR2, CCKBR, GRPR KMT2A 1795/4885MEN1 54/4885NLRP3 4101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.